Raz R, Weisskopf MG, Davidovitch M, Pinto O, Levine H
It is estimated that 30 to 90% of athletes experience these gastrointestinal symptoms
The oral form is a newer option and is mainly used for diabetes treatment
Mounjaro pulled in sales of $5.1 billion in 2023, while Zepbound produced $176 million in six weeks, following the US Food and Drug Administration (FDA) approval in November 2023
There are a number of health conditions that prevent patients from being able to maintain sufficient levels of hydration or minerals in the body naturally, whether they are experiencing nausea and are unable to keep any fluids down or have an underlying condition that prevents them from effectively absorbing vitamins and minerals that are consumed in their diet
The regulatory status of compounded GLP-1 medications continues to evolve